FDA NDC Directory · JSON-LD · Markdown

Fluvoxamine Maleate

NDC 0228-2849 · HUMAN PRESCRIPTION DRUG · CAPSULE, EXTENDED RELEASE

Labeler / ManufacturerActavis Pharma, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA091482
Dosage form / routeCAPSULE, EXTENDED RELEASE · ORAL
Active ingredientsFLUVOXAMINE MALEATE (150 mg/1)
Marketing started20140805
Package count1

External sources

Source: openFDA. Public-domain (CC0).